Dr. Reddy’s receives approval from the US Food and Drug Administration (USFDA) for its rituximab biosimilar. The approval comes after the USFDA conducts a Pre-License Inspection (PLI) at the company’s biologics manufacturing facility in Bachupally, Hyderabad. Multiple reports describe the development as an FDA nod that follows the inspection process related to the manufacturing site. The information provided across sources focuses on the approval and the fact that it is linked to the USFDA’s inspection of Dr. Reddy’s facility. The reports do not add details on product specifications, expected launch timelines, or market availability. Overall, the coverage centers on the regulatory milestone and the inspection step that precedes approval. The biosimilar is tied to rituximab, a monoclonal antibody used in certain cancer and immune-related conditions, though the shared articles do not specify the approved indications. The sources present the USFDA approval as the key event.
Dr. Reddy’s receives USFDA approval for rituximab biosimilar
Dr. Reddy’s receives approval from the US Food and Drug Administration (USFDA) for its rituximab biosimilar. The approval comes after the USFDA conducts a Pre-License Inspection (PLI) at the company’s...
- Dr. Reddy’s receives USFDA approval for a rituximab biosimilar.
- The approval follows a USFDA Pre-License Inspection (PLI).
- The PLI is conducted at Dr. Reddy’s biologics manufacturing facility in Bachupally, Hyderabad.
- Reports agree the regulatory inspection is linked to the approval outcome.
- The coverage focuses on the approval and inspection; it does not provide additional launch or indication details.
The approval follows Pre-License Inspection (PLI) conducted by the USFDA at the company’s biologics manufacturing facility in Bachupally, Hyderabad.
3 hours ago
Irish papers’ front pages vary by day, with content summaries listed by BreakingNews.ie
BreakingNews.ie publishes recurring posts summarizing Irish newspapers’ front pages for multiple days of the week. The s...
Audi unveils Q9 flagship SUV with three-row seating and larger dimensions
Audi has unveiled the all-new Q9, described across outlets as the brand’s flagship and largest SUV to date, positioned a...
Federal judge blocks Minnesota’s prediction market ban, pending legal challenge
A federal judge blocks Minnesota from enforcing a new state law restricting prediction markets, including platforms such...